BioNTech Agrees to Buy Scholar Rock Priority Review Voucher

Recovered source-gap item: BioNTech announced November 10 an agreement to acquire Scholar Rock’s FDA priority review voucher for $205 million cash. The voucher can shorten a future eligible application review, but is not a…




